Loading the map…
Private limited company registered in Cardiff, classed under “Wholesale of pharmaceutical goods”.
Headline figures
FY to Dec 2025 · Company only
Turnover
For subscribers
Profit after tax
−£850k
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
Retained reserves
For subscribers
What the numbers say
4 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2021* | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Profit after tax | −£850k | ||||
| Turnover | |||||
| Net assets | |||||
| Cash | |||||
| Employees | |||||
| Retained reserves |
Every figure for all 5 years
“—” means we did not find the figure in a source; it is never filled with an estimate. * Restated: the next year's accounts printed different figures for this year, and those later figures are shown.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Fixed assets | ||||
| Current assets | ||||
| of which debtors | ||||
| of which cash | ||||
| Creditors due within a year | ||||
| Net current assets | ||||
| Net assets | ||||
| Ratios | ||||
| Profit marginProfit after tax as a share of turnover | ||||
| Return on equityProfit after tax as a share of net assets | ||||
| Current ratioCurrent assets for every £1 owed within a year | ||||
| Cash ratioCash for every £1 owed within a year | ||||
| Creditors to assetsEverything owed to creditors as a share of fixed plus current assets | ||||
| Turnover per employeeTurnover divided by average staff | ||||
| Debtor daysDays of turnover owed by customers at the year end | ||||
7 balance-sheet lines and 7 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Timeline
Checked 2026-10-28
- AccountsAccounts for a medium company made up to 31 December 2025
- AccountsAccounts for a medium company made up to 31 December 2024
- AccountsFull accounts made up to 31 December 2023
- OwnershipNotification of Permira Vii Investment Platform Limited as a person with significant control on 16 December 2020
- OwnershipWithdrawal of a person with significant control statement on 21 February 2024
- AccountsAccounts for a small company made up to 31 December 2022
- DirectorsAppointment of Dr Maximilian Von Wülfing as a director on 10 January 2023
- DirectorsTermination of appointment of Craig Andrew Bowen as a director on 5 January 2023
- DirectorsTermination of appointment of Jan Christoph Koch as a director on 5 January 2023
- DirectorsAppointment of Mr Mark Anthony Slater as a director on 10 October 2022
- AccountsTotal exemption full accounts made up to 31 December 2021
- DirectorsDirector's details changed for Mr Craig Andrew Bowen on 1 April 2022
14 earlier
- AddressRegistered office address changed from Unit 12 Farnborough Business Centre Eelmoor Farnborough Hampshire GU14 7XA United Kingdom to Tudor House 16 Cathedral Road Cardiff CF11 9L…
- AccountsAmended total exemption full accounts made up to 31 December 2020
- AccountsTotal exemption full accounts made up to 31 December 2020
- AccountsTotal exemption full accounts made up to 31 December 2019
- DirectorsAppointment of Mr Craig Andrew Bowen as a director on 27 September 2019
- AccountsTotal exemption full accounts made up to 31 December 2018
- SharesStatement of capital following an allotment of shares on 10 December 2018 · GBP 305,000
- AccountsAccounts for a dormant company made up to 31 December 2017
- AddressRegistered office address changed from C/O Hackwood Secretaries Limited One Silk Street London EC2Y 8HQ United Kingdom to Unit 12 Farnborough Business Centre Eelmoor Farnborough…
- DirectorsTermination of appointment of Daniel Wiest as a director on 6 April 2018
- DirectorsAppointment of Jan Christoph Koch as a director on 6 April 2018
- NameCertificate of change of name
- AccountsCurrent accounting period shortened from 31 August 2018 to 31 December 2017
- IncorporationIncorporation
- Address
From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.
Questions people ask
›What does Neuraxpharm UK do?
Private limited company registered in Cardiff, classed under “Wholesale of pharmaceutical goods”.
›How much turnover does Neuraxpharm UK make?
Answered in the full report
›Is Neuraxpharm UK profitable?
No: it made a loss after tax of £850k in the year to 31 December 2025, its latest filed accounts.
›How many people work at Neuraxpharm UK?
Answered in the full report
›Who runs and owns Neuraxpharm UK?
Its directors are Mark Anthony Slater, Maximilian Von Wülfing. Its owners are shown to subscribers.
›Where is Neuraxpharm UK based?
Its registered office is Tudor House, 16 Cathedral Road, Cardiff, CF11 9LJ, in Cardiff.
›When was Neuraxpharm UK founded?
Neuraxpharm UK Limited was incorporated on 16 August 2017.
›Is Neuraxpharm UK still trading?
The register lists Neuraxpharm UK Limited as active.